Arcturus Therapeutics Holdings (ARCT) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$5.0 million.
- Arcturus Therapeutics Holdings' Change in Account Payables fell 3367.78% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year increase of 4224.28%. This contributed to the annual value of $1.9 million for FY2024, which is 18556.75% up from last year.
- Arcturus Therapeutics Holdings' Change in Account Payables amounted to -$5.0 million in Q3 2025, which was down 3367.78% from $4.4 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Change in Account Payables registered a high of $11.8 million during Q1 2023, and its lowest value of -$12.7 million during Q4 2023.
- In the last 5 years, Arcturus Therapeutics Holdings' Change in Account Payables had a median value of -$1.0 million in 2025 and averaged -$306315.8.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Change in Account Payables crashed by 56927.78% in 2022, and later soared by 2689090.91% in 2023.
- Arcturus Therapeutics Holdings' Change in Account Payables (Quarter) stood at $1.8 million in 2021, then plummeted by 569.28% to -$8.4 million in 2022, then plummeted by 50.76% to -$12.7 million in 2023, then skyrocketed by 76.94% to -$2.9 million in 2024, then tumbled by 71.77% to -$5.0 million in 2025.
- Its last three reported values are -$5.0 million in Q3 2025, $4.4 million for Q2 2025, and -$1.0 million during Q1 2025.